PanoramicaGraficoNotizieSchermataTrader

UBS Knock-Out ABL/  DE000UM7V4N0  /

EUWAX
08/11/2024  21:54:38 Var.+0.13 Denaro22:00:24 Lettera22:00:24 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
1.60EUR +8.84% -
Quantità in denaro: -		 -
Quantità in lettera: -		 ABBOTT LABS 100.1634 - 31/12/2078 Call
TeleTrader 16/10 US opens flat after mortgage data
TeleTrader 16/10 Abbott Labs reports Q3 sales of $10.6B, up 4.9%
TeleTrader 16/10 US flat premarket after yesterday's tech stock fall
TeleTrader 13/10 WEEKLY PREVIEW: Earnings reports and economic updates
GlobeNewswire 06/08 Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
TeleTrader 18/07 Abbott's Q2 net earnings down by 5.3% to $1.3B
TeleTrader 18/07 US mostly up premarket ahead of earnings
Newsfile Corp 11/07 Bloodstream Infections - From Threats to Solutions
GlobeNewswire 11/07 U.S. Cannabis Market Soars Amid Legal Reforms, But Safety Concerns Persist
GlobeNewswire 06/06 Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire 04/06 Amarin Board of Directors Announces CEO Transition
GlobeNewswire 23/05 Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
GlobeNewswire 16/05 CVRx Announces Key Senior Leadership Team Hires
GlobeNewswire 09/05 R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
TeleTrader 17/04 Abbott Labs' Q1 sales up 2.2% to $9.9B
Newsfile Corp 12/04 IRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in Columbus
GlobeNewswire 11/04 Black Diamond Therapeutics Announces Changes to Board of Directors
GlobeNewswire 25/03 Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire 15/03 Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire 08/02 60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer
GlobeNewswire 06/02 Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer
GlobeNewswire 01/02 Vestaron announces CEO transition, appoints Juan Estupinan as Interim CEO
TeleTrader 24/01 Abbott Labs' Q4 sales up 1.5% to $10.2B
TeleTrader 24/01 US up premarket with data, earnings to come
TeleTrader 22/01 Earnings preview: Tesla takes center stage